Add like
Add dislike
Add to saved papers

IMMOBILIZING MUSKOX ( OVIBOS MOSCHATUS) UNDER HIGH ARCTIC CONDITIONS.

Immobilizing and handling large, free-ranging animals without proper facilities in harsh environmental conditions poses significant challenges. During two field expeditions, a total of 29 female muskoxen ( Ovibos moschatus) were immobilized in Northeast Greenland (74°N, 20°E). Fixed doses of immobilizing drugs were used regardless of animal size: 2 mg etorphine, 30 mg xylazine, 0.3 mg medetomidine, and 40 mg ketamine. Physiologic and behavioral monitoring was performed during the second expedition on 15 female muskoxen. The observed heart rates were 35-58 beats/min and respiratory rates were 25-30 breaths/min. Mean arterial pressures measured using oscillometry ranged between 117-142 mmHg. Pulse oximeter readings ranged from 91-98% with oxygen supplementation, nasal end-tidal carbon dioxide values were 24-42 mmHg, and rectal temperature ranged from 38.9-39.6°C. Induction time was 6-8 min, recovery time 2-6 min after reversal, and duration of anesthesia was 50-100 min. This anesthetic regime thus provided reliable immobilization with minimal pathophysiologic alterations.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app